Products for Research Use Only

Mibefradil

CAT: 0804-HY-15553-03Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-15553-03Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mibefradil (Ro 40-5967) is a calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50s of 2.7 μM and 18.6 μM for T-type and L-type currents, respectively[1].
CAS Number
116644-53-2
Product Name Alternative
Ro 40-5967
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/mibefradil.html
Purity
99.29
Solubility
10 mM in DMSO
Smiles
O=C(O[C@@]1(CCN(CCCC2=NC3=CC=CC=C3N2)C)[C@@H](C(C)C)C4=C(C=C(F)C=C4)CC1)COC
Molecular Formula
C29H38FN3O3
Molecular Weight
495.63
Precautions
H302, H315, H319, H335
References & Citations
[1]Mehrke G, et al. The Ca (++) -channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels. J Pharmacol Exp Ther. 1994 Dec;271 (3) :1483-8.|[2]Brain KL, et al. The sources and sequestration of Ca (2+) contributing to neuroeffector Ca (2+) transients in the mouse vas deferens. J Physiol. 2003 Dec 1;553 (Pt 2) :627-35.|[3]Yu YF, et al. Protection of the cochlear hair cells in adult C57BL/6J mice by T-type calcium channel blockers. Exp Ther Med. 2016 Mar;11 (3) :1039-1044.|[4]Shiue SJ, et al. Chronic intrathecal infusion of T-type calcium channel blockers attenuates CaV3.2 upregulation in nerve-ligated rats. Acta Anaesthesiol Taiwan. 2016 Oct 17. pii: S1875-4597 (16) 30071-6.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
L-type calcium channel; T-type calcium channel
Citation 01
Biochem Biophys Res Commun. 2020 Feb 19;522 (4) :862-868.|Br J Pharmacol. 2021 Jan;178 (2) :346-362.|Eur J Pharmacol. 2021 Feb 5;892:173782.|Front Pharmacol. 2022 Feb 23:13:816133.|J Cell Physiol. 2021 Sep;236 (9) :6548-6558.|Mediators Inflamm. 2020 Nov 10;2020:3691701.|Theriogenology. 2021 Jan 1;159:140-146.|ACS Nano. 2024 Nov 12;18 (45) :31451-31465.|Biochem Biophys Res Commun. 2025 Sep 19:785:152676.|Front Pharmacol. 2022 Feb 23;13:816133.|PLoS Biol. 2024 Mar 25;22 (3) :e3002565.|Res Sq. 2024 Jun 11.|Small. 2024 Aug 10:e2403381.

Chemical Information

Mibefradil

Mibefradil is a member of tetralins. It has a role as a T-type calcium channel blocker.

CAS Number116644-53-2
PubChem CID60663
IUPAC Name[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate
Molecular FormulaC29H38FN3O3
Molecular Weight495.6
XLogP5.8
Topological Polar Surface Area67.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count12
Heavy Atom Count36
Formal Charge0
Complexity709
SMILES
CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F
InChI
InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1
InChIKey
HBNPJJILLOYFJU-VMPREFPWSA-N
Chemical Structure
2D Structure
2D structure of Mibefradil
CAS: 116644-53-2
CID: 60663
Formula: C29H38FN3O3
MW: 495.6
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight495.6
XLogP35.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count12
Exact Mass495.28972024
Monoisotopic Mass495.28972024
Topological Polar Surface Area67.5 Ų
Heavy Atom Count36
Formal Charge0
Complexity709
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Popular Products